These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 15050603

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Gray matter involvement in multiple sclerosis.
    Pirko I, Lucchinetti CF, Sriram S, Bakshi R.
    Neurology; 2007 Feb 27; 68(9):634-42. PubMed ID: 17325269
    [Abstract] [Full Text] [Related]

  • 23. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
    Zivadinov R, Locatelli L, Cookfair D, Srinivasaraghavan B, Bertolotto A, Ukmar M, Bratina A, Maggiore C, Bosco A, Grop A, Catalan M, Zorzon M.
    Mult Scler; 2007 May 27; 13(4):490-501. PubMed ID: 17463072
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    Oreja-Guevara C, Charil A, Caputo D, Cavarretta R, Sormani MP, Filippi M.
    Arch Neurol; 2006 May 27; 63(5):736-40. PubMed ID: 16682543
    [Abstract] [Full Text] [Related]

  • 26. Gender-related differences in MS: a study of conventional and nonconventional MRI measures.
    Antulov R, Weinstock-Guttman B, Cox JL, Hussein S, Durfee J, Caiola C, Dwyer MG, Bergsland N, Abdelrahman N, Stosic M, Hojnacki D, Munschauer FE, Miletic D, Zivadinov R.
    Mult Scler; 2009 Mar 27; 15(3):345-54. PubMed ID: 19028830
    [Abstract] [Full Text] [Related]

  • 27. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis.
    Sarchielli P, Presciutti O, Tarducci R, Gobbi G, Alberti A, Pelliccioli GP, Chiarini P, Gallai V.
    J Neurol; 2002 Jul 27; 249(7):902-10. PubMed ID: 12140676
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct 27; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.
    Sanfilipo MP, Benedict RH, Sharma J, Weinstock-Guttman B, Bakshi R.
    Neuroimage; 2005 Jul 15; 26(4):1068-77. PubMed ID: 15961046
    [Abstract] [Full Text] [Related]

  • 35. Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis.
    Riccitelli G, Rocca MA, Pagani E, Martinelli V, Radaelli M, Falini A, Comi G, Filippi M.
    Mult Scler; 2012 Jul 15; 18(7):1027-37. PubMed ID: 22422807
    [Abstract] [Full Text] [Related]

  • 36. The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
    Tartaglia MC, Narayanan S, Francis SJ, Santos AC, De Stefano N, Lapierre Y, Arnold DL.
    Arch Neurol; 2004 Feb 15; 61(2):201-7. PubMed ID: 14967766
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
    De Stefano N, Bartolozzi ML, Nacmias B, Zipoli V, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, Amato MP.
    Arch Neurol; 2004 Apr 15; 61(4):536-40. PubMed ID: 15096402
    [Abstract] [Full Text] [Related]

  • 40. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
    Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M, Zackowski K, Bastian A, Smith SA, Pomper MG, Moser HW, Raymond GV.
    Neurology; 2005 Jan 25; 64(2):304-10. PubMed ID: 15668429
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.